Koers Pharmocann Global Ltd TEL AVIV STOCK EXCHANGE
Aandelen
PMCN
IL0010968902
Gezondheidszorgvoorzieningen & -diensten
Omzet 2022 | 22,66 mln. 6,1 mln. 5,67 mln. | Omzet 2023 | 14,41 mln. 3,88 mln. 3,61 mln. | Marktkapitalisatie | 3,12 mln. 841K 781K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -25 mln. -6,73 mln. -6,26 mln. | Nettowinst (verlies) 2023 | -9 mln. -2,42 mln. -2,25 mln. | EV/omzet 2022 | 0,4 x |
Nettoliquiditeiten 2022 | 925K 249K 231K | Nettoliquiditeiten 2023 | 768K 207K 192K | EV/omzet 2023 | 0,16 x |
K/w-verhouding 2022 |
-0,26
x | K/w-verhouding 2023 |
-0,28
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 51,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 40 | 17-06-19 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 29-12-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 05-12-22 |
Locar Gila
BRD | Director/Board Member | 51 | 29-11-22 |
Director/Board Member | 43 | 29-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,51% | 275 mln. | |
+36,08% | 274 mln. | |
+48,84% | 195 mln. | |
-14,29% | 145 mln. | |
+59,30% | 142 mln. | |
-32,64% | 141 mln. | |
+147,89% | 140 mln. | |
-7,69% | 80,05 mln. | |
+150,00% | 75,33 mln. |